U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 685 records

Showing results for "cardiovascular".
Users also searched for: statin

  1. Home | AHRQ Effective Health Care Program (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/methods-guide_prepublication-draft_03-2011.pdf
    January 01, 2011 - Jul. 25, 2017 Omega-3 Fatty Acids and Cardiovascular

  2. Home | AHRQ Effective Health Care Program (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/mrsascreening_protocol_20110602.pdf
    August 10, 2017 - Jul. 25, 2017 Omega-3 Fatty Acids and Cardiovascular

  3. Home | AHRQ Effective Health Care Program (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/20090427identtifyingtopics.pdf
    August 10, 2017 - Jul. 25, 2017 Omega-3 Fatty Acids and Cardiovascular

  4. Home | AHRQ Effective Health Care Program (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/decision-models-guidance-160915.pdf
    August 10, 2017 - Jul. 25, 2017 Omega-3 Fatty Acids and Cardiovascular

  5. Home | AHRQ Effective Health Care Program (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/module-i-ahrqs-vision-for-theory-and-principles-of-stakeholder-engagement.pdf
    August 10, 2017 - Jul. 25, 2017 Omega-3 Fatty Acids and Cardiovascular

  6. Evidence Report on the (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-pain_research-protocol.pdf
    August 05, 2010 - August 05, 2010 bleeding, but they also appear to be associated with increased rates of serious cardiovascular … • Demographic subgroups: age, sex, and race • Coexisting diseases: cardiovascular conditions, such …  Cardiovascular: stroke, MI, CHF, hypertension and angina  GI: perforations, symptomatic gastroduodenal … Outcomes will include improvements in osteoarthritis symptoms, cardiovascular and gastrointestinal adverse … including sex, age, ethnicity, diagnosis, comorbidities, concomitant medications, GI bleeding risk, cardiovascular

  7. Effective Health Care (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0477_11-01-2011.pdf
    January 01, 2011 - Nonpharmacologic therapies: cardiovascular exercise; cognitive behavioral therapy (CBT); massage therapy

  8. Antiplatelet-Treatment Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
    September 01, 2013 - Disease and Clinical Setting Approximately 82 million Americans currently suffer from some form of cardiovascular … All published studies enrolled patients with ischemic cardiovascular disease. … outcomes, either (1) cardiovascular death or nonfatal myocardial infarction or (2) cardiovascular death … Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease. … CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events.

  9. A Multicenter, Observational Cohort Study to Assess the Cardiovascular Risks of Medications Prescribed for Attention Deficit Hyperactivity Disorder | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/adhd-medicines-risks/abstract

  10. Cannabis-2023-Update-Surv-Rep-3 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-update-surv-rep-3.pdf
    January 01, 2023 - Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study.

  11. Misuse of Prescription Stimulants in Adults (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol-amendment.pdf
    November 26, 2024 - market for prescription stimulants.8, 9 Misuse of prescription stimulants may be associated with cardiovascular … KQ2: What are the shorter term (e.g., overdose) and longer term (e.g., cardiovascular) health consequences … Comparator, if applicable • Outcome o Short-term  Overdoses, fatal and non-fatal  Health measures (cardiovascular

  12. MEDLINE Searches (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
    March 01, 2009 - System/pp, de 8 5 or 6 or 7 9 4 and 8 10 exp Cardiovascular System/ 11 exp Cardiovascular Diseases … Cardiovascular effects of raloxifene: the arterial and venous systems. … SERMs and cardiovascular disease in women. How do these agents affect risk? … Effects of SERMs on important indicators of cardiovascular health: lipoproteins, hemostatic factors, … Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease

  13. Disparities-Quality-Improvement Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_executive.pdf
    August 01, 2012 - Nineteen papers met criteria; they represented 14 studies of cancer, cardiovascular disease, depression … Connett and Stamler, 198417 RCT Cardiovascular disease: coronary artery disease and hypertension … Olomu et al., 201028 Retrospective cohort (historic controls) Cardiovascular disease: coronary artery … One study of cardiovascular risk factor modification showed no meaningful reduction in health disparities … For studies of cardiovascular risk factor control, outcomes consisted of intermediate clinical variables

  14. Comparative Effectiveness Research to Improve Anemia Management and Cardiovascular Disease Outcomes in End-Stage Renal Disease (ESRD) | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/renal-disease-anemia/abstract

  15. Prevention, Diagnosis, and Management of Opioids, Opioid Misuse and Opioid Use Disorder in Older Adults: Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioids-oa-protocol.pdf
    June 29, 2019 - What outcomes should be captured specifically for older adults (falls, cognitive function, cardiovascular … Any outcome, including: o Person-level clinical outcomes (e.g., death, falls, cognitive function, cardiovascular … We will extract all eligible specific outcome categories (e.g., opioid misuse, fall, cardiovascular … Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis. … Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies

  16. Nephropathy-Contrast-Induced Executive-2016 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_executive-2016.pdf
    January 01, 2016 - difference between IOCM and LOCMs with regard to need for renal replacement therapy (5 studies), cardiovascular … found no difference between LOCM types or between LOCM and IOCM in potential sequelae of CIN, such as cardiovascular … included such studies found no conclusive evidence that IOCM is superior to LOCM with respect to cardiovascular … Cardiovascular interventions. 2009(5):430-7. PMID: 20031753. 28. … A meta-analysis of the risk of total cardiovascular events of isosmolar iodixanol compared with low-osmolar

  17. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypothyroidism-hyperthyroidism-screening-treatment_executive.pdf
    October 01, 2011 - hypothyroidism were weight change; measures of well-being, including but not limited to cognition and memory; cardiovascular … hyperthyroidism were weight change; measures of well- being, including but not limited to cognition and memory; cardiovascular … health-related quality of life or symptoms, and the trials were not suitable to assess survival or cardiovascular … review,1 and four were not included in the 2007 Cochrane review.3 None of the trials evaluated long-term cardiovascular … The evidence was insufficient to assess or quantify the effect of screening on cardiovascular events

  18. For the elderly taking cardiovasculare medications, what are the comparative risks and benefits of commonly used herbal supplements. | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-the-elderly-taking-cardiovasculare-medications-what-are-the-comparative-risks-and-benefits-of-commonly-used-herbal-supplements

  19. women-hiv-protocol-160301 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
    March 01, 2016 - The comorbid conditions of interest include cardiovascular disease, hypertension, type-2 diabetes, obesity … It also accelerates the onset and progression of chronic diseases of aging, including cardiovascular … Source: www.effectivehealthcare.ahrq.gov Published online: March 1, 2016 6 HIV-associated dementia), cardiovascular … HIV infection and cardiovascular disease. European heart journal. 2014;35(21):1373-1381. 12. … Journal of cardiovascular medicine (Hagerstown, Md.). 2015;16(12):839-843. 13.

  20. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2023 Update -- Surveillance Report 4 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4.pdf
    January 01, 2023 - Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study.
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites